Nature Communications (May 2024)

Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity

  • Shengjun Wang,
  • Wei Ran,
  • Lingyu Sun,
  • Qingchi Fan,
  • Yuanqi Zhao,
  • Bowen Wang,
  • Jinghong Yang,
  • Yuqi He,
  • Ying Wu,
  • Yuanyuan Wang,
  • Luoyi Chen,
  • Arpaporn Chuchuay,
  • Yuyu You,
  • Xinhai Zhu,
  • Xiaojuan Wang,
  • Ye Chen,
  • Yanqun Wang,
  • Yao-Qing Chen,
  • Yanqiu Yuan,
  • Jincun Zhao,
  • Yang Mao

DOI
https://doi.org/10.1038/s41467-024-48503-x
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 17

Abstract

Read online

Abstract The multibasic furin cleavage site at the S1/S2 boundary of the spike protein is a hallmark of SARS-CoV-2 and plays a crucial role in viral infection. However, the mechanism underlying furin activation and its regulation remain poorly understood. Here, we show that GalNAc-T3 and T7 jointly initiate clustered O-glycosylations in the furin cleavage site of the SARS-CoV-2 spike protein, which inhibit furin processing, suppress the incorporation of the spike protein into virus-like-particles and affect viral infection. Mechanistic analysis reveals that the assembly of the spike protein into virus-like particles relies on interactions between the furin-cleaved spike protein and the membrane protein of SARS-CoV-2, suggesting a possible mechanism for furin activation. Interestingly, mutations in the spike protein of the alpha and delta variants of the virus confer resistance against glycosylation by GalNAc-T3 and T7. In the omicron variant, additional mutations reverse this resistance, making the spike protein susceptible to glycosylation in vitro and sensitive to GalNAc-T3 and T7 expression in human lung cells. Our findings highlight the role of glycosylation as a defense mechanism employed by host cells against SARS-CoV-2 and shed light on the evolutionary interplay between the host and the virus.